ホーム>>Signaling Pathways>> Microbiology & Virology>> Antibiotic>>Enterocin

Enterocin (Synonyms: Vulgamycin)

カタログ番号GC10193

抗生物質であるエンテロシンは、グラム陽性菌とグラム陰性菌に対して静的な活性を持ち、真菌と酵母に対しては活性を持ちません。

Products are for research use only. Not for human use. We do not sell to patients.

Enterocin 化学構造

Cas No.: 59678-46-5

サイズ 価格 在庫数 個数
1mg
$335.00
在庫あり
5mg
$1,506.00
在庫あり

Tel:(909) 407-4943 Email: sales@glpbio.com

顧客レビュー

カスタマーレビューに基づきます。

  • GlpBio Citations

    GlpBio Citations
  • Bioactive Compounds Premium Provider

    Bioactive Compounds Premium Provider

Sample solution is provided at 25 µL, 10mM.

Description Chemical Properties Product Documents Related Products

Enterocin is an antibiotic isolated from cultures of two strains of Streptomyces, Streptomyces candidus var. enterostaticus WS-8096 and variant M-127 of Streptomyces viridochromogenes. This antibiotic shows activity against Gram-positive and Gram-negative bacteria, especially against the Enterobacteriaceae [1]. Enterocin was named for its strong activity against Enterobacteriaceae.

The elementary analysis and mass spectroscopic measurement suggested that the molecular formula was C72H20O10. The ultraviolet absorption gave two maximal peaks at 250 nm and 283 nm in methanol [1]. The mechanism of enterocin is unknown. Enterocin acts synergistically with streptomycin and chloramphenicol. The genetics of enterocin biosynthesis has been extensively investigated. Enterocin is a small molecular weight secondary metabolite [1].

Reference:
[1] Miyairi N, SAKAI H E I I, KONOMI T, et al.  Enterocin, a new antibiotic [J]. The Journal of antibiotics, 1976, 29(3): 227-235.

レビュー

Review for Enterocin

Average Rating: 5 ★★★★★ (Based on Reviews and 7 reference(s) in Google Scholar.)

5 Star
100%
4 Star
0%
3 Star
0%
2 Star
0%
1 Star
0%
Review for Enterocin

GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.

Required fields are marked with *

You may receive emails regarding this submission. Any emails will include the ability to opt-out of future communications.